Big pharma gets creative as price pressures mount

October 24, 2012

Austerity budgets and competition from cheap generics are forcing big drugmakers to get creative about pricing – and that’s making an already fragmented European drugs market even more opaque, says Reuters European pharmaceuticals correspondent Ben Hirschler.

Ben Hirschler’s full report on big pharma’s pricing tactics can be read here.

No comments so far

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see